Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
Merck KGaA to try again to get approval for MS pill cladribine
Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
Default network activity is a sensitive and specific biomarker of memory in multiple sclerosis.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
Type 1 immune response in progressive multiple sclerosis.
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two.
Sustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function.
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.
Spasticity: pathophysiology, evaluation and management.
Is the treatment of multiple sclerosis headed in the wrong direction?
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Pathology and disease mechanisms in different stages of multiple sclerosis.
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Pages
« first
‹ previous
…
179
180
181
182
183
184
185
186
187
…
next ›
last »